Helen of Troy shares turn defensive on weakening sales, revised guidance

[ad_1] uschools Federal Reserve Bank of Boston President Susan Collins endorsed Thursday a more cautious strategy for future interest-rate cuts as the U.S economic outlook faces “considerable uncertainty.” Collins noted that inflation remains sticky and “I expect inflation in 2025 to run somewhat higher [ad_2]

[ad_1] hapabapa/iStock Editorial via Getty Images Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. In a Citizen Petition posted on Regulations.gov, Novo Nordisk (NVO) noted [ad_2]

[ad_1] Mlenny/E+ via Getty Images Welcome to Seeking Alpha’s Catalyst Watch – a breakdown of some of next week’s actionable events that stand out. Read more about the events that may impact stock prices next week. Monday – December 30 Volatility watch – KULR Technology [ad_2]